COVID-19 vaccines significantly reduce the risk of hospitalization due to COVID-19: for example, the BioNTech / Pfizer vaccine reduces this risk by 85%, and the AstraZeneca drug - by 94%, as experts from Scotland found.

According to DW.com, Scottish researchers found that the very first dose of the vaccine developed by the German company BioNTech together with the American Pfizer, by the fourth week after vaccination, reduces the risk of hospitalization by 85%. And a drug from the British-Swedish pharmaceutical company AstraZeneca and the University of Oxford reduces this risk by 94%.

These data, according to scientists, give grounds for optimism and for accelerating the process of vaccination of the population.

According to scientists, every fifth Scot (21%) has already been vaccinated against coronavirus: about 650,000 people have used the drug from BioNTech / Pfizer, and 490,000 people have used the AstraZeneca development.